Market Tracker

10/20 4:45pm ET

Celgene Corp (NASDAQ:CELG)

92.00
Data as of Oct 20
 +3.88 / +4.40%
Today’s Change
66.85
Today|||52-Week Range
96.50
+8.90%
Year-to-Date

Today’s Trading

Previous close88.12
Today’s open88.84
Day’s range88.57 - 92.55
Volume7,980,702
Average volume (3 months)4,435,559
Market cap$70.5B
Dividend yield--
Data as of 3:59pm ET, 10/20/2014

Growth & Valuation

Earnings growth (last year)+2.12%
Earnings growth (this year)+23.32%
Earnings growth (next 5 years)+26.00%
Revenue growth (last year)+19.49%
P/E ratio53.2
Price/Sales10.78
Price/Book12.92

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.52+0.83%
ABTAbbott Laboratories+0.60+1.47%
ACTActavis PLC+1.94+0.86%
BMYBristol-Myers Squibb...+0.14+0.28%
Data as of 4:01pm ET, 10/20/2014

Financials

Next reporting dateOctober 23, 2014
EPS forecast (this quarter)$0.95
Annual revenue (last year)$6.5B
Annual profit (last year)$1.4B
Net profit margin22.36%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts